Clinical trials recruiting in Kutná Hora, Czechia

Phase breakdown

Conditions recruiting in Kutná Hora, Czechia

Recruiting trials in Kutná Hora, Czechia

• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
  NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
  NCT06651567 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female)
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kutná Hora, Czechia?

3 recruiting trials have at least one study site in Kutná Hora, Czechia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.